A new material similar to that used by the US military to treat traumatic injuries is showing promise as the next novel treatment for bleeding ulcers, a condition that commonly affects up to 15 ...

The leading cause of death due to injuries in war is excessive bleeding. A KAIST research team, in which an Army Major ...

TORONTO, Ont., October 13, 2010 — A new material similar to that used by the U.S. Military to treat traumatic injuries is showing promise as the next novel treatment for bleeding ulcers, a condition ...

T&R Biofab announced on the 13th that it has received permission for domestic sales of a powder-type hemostatic agent product from the Ministry of Food and Drug Safety. This hemostatic agent is a ...

Marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Addressing intraoperative bleeding ...

In the study of over 200 patients, 90.1% of those who received TC-325 had their bleeding controlled within 30 days, as compared to 81.4% of those who received standard treatment, meeting criteria for ...

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable ...

Global Hemostatic Powder Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 recently presented by MarketsandResearch.biz endows with an exhaustive survey of the market and ...

A hemostatic powder applied during an upper endoscopy as an early intervention was effective for treating acute variceal bleeding in patients with liver cirrhosis, according to research published in ...

Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...